We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Julie Klish Tibbets Alston & Bird LLP

Results 1 to 5 of 64



FDA streamlines CGMP compliance for combination products *

USA - January 24 2013
On January 22, 2013, the U.S. Food and Drug Administration (FDA) published its final rule implementing current good manufacturing practice (CGMP)…

Co-authors: Donald E. Segal, Guillermo E. Cuevas.


FDA acceptance policies on PMA and 510(k) submissions *

USA - January 14 2013
On December 31, 2012, FDA issued two guidance documents detailing the agency's approach to reviewing the completeness of medical device applications…

Co-authors: Donald E. Segal, Guillermo E. Cuevas.


United States v. Caronia – watershed decision on off-label promotion? *

USA - December 11 2012
The regulatory landscape regarding off-label drug promotion may be changing in light of the Second Circuit’s recent decision in United States v. Caronia.

Co-authors: Guillermo E. Cuevas, Marc J. Scheineson.


On the horizon – what to expect from FDA in 2013 *

USA - November 15 2012
With the reelection of President Obama, the U.S. Food and Drug Administration (FDA) is likely to continue its current high level of regulatory oversight and enforcement.

Co-authors: Guillermo E. Cuevas.


Ripe for congressional reform *

USA - November 15 2012
In response to the NECC fungal meningitis outbreak, Representative Edward Markey (D-MA) introduced new legislation to expand FDA authority over prescription drug compounders.

Co-authors: Guillermo E. Cuevas.


Next »